Literature DB >> 19403660

FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism.

Aaron J Thomas1, Carol A Erickson.   

Abstract

The first neural crest cells to emigrate from the neural tube are specified as neurons and glial cells and are subsequently followed by melanocytes of the skin. We wished to understand how this fate switch is controlled. The transcriptional repressor FOXD3 is expressed exclusively in the neural/glial precursors and MITF is expressed only in melanoblasts. Moreover, FOXD3 represses melanogenesis. Here we show that avian MITF expression begins very early during melanoblast migration and that loss of MITF in melanoblasts causes them to transdifferentiate to a glial phenotype. Ectopic expression of FOXD3 represses MITF in cultured neural crest cells and in B16-F10 melanoma cells. We also show that FOXD3 does not bind directly to the MITF promoter, but instead interacts with the transcriptional activator PAX3 to prevent the binding of PAX3 to the MITF promoter. Overexpression of PAX3 is sufficient to rescue MITF expression from FOXD3-mediated repression. We conclude that FOXD3 controls the lineage choice between neural/glial and pigment cells by repressing MITF during the early phase of neural crest migration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19403660      PMCID: PMC2680109          DOI: 10.1242/dev.031989

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  64 in total

1.  Interaction of the pRB-family proteins with factors containing paired-like homeodomains.

Authors:  O Wiggan; A Taniguchi-Sidle; P A Hamel
Journal:  Oncogene       Date:  1998-01-15       Impact factor: 9.867

2.  Spontaneous transdifferentiation of quail pigmented epithelial cell is accompanied by a mutation in the Mitf gene.

Authors:  M Mochii; T Ono; Y Matsubara; G Eguchi
Journal:  Dev Biol       Date:  1998-04-15       Impact factor: 3.582

3.  Avian winged helix proteins CWH-1, CWH-2 and CWH-3 repress transcription from Qin binding sites.

Authors:  B S Freyaldenhoven; M P Freyaldenhoven; J S Iacovoni; P K Vogt
Journal:  Oncogene       Date:  1997-07-24       Impact factor: 9.867

4.  Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics.

Authors:  M Tachibana; K Takeda; Y Nobukuni; K Urabe; J E Long; K A Meyers; S A Aaronson; T Miki
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

5.  Sox10, a novel transcriptional modulator in glial cells.

Authors:  K Kuhlbrodt; B Herbarth; E Sock; I Hermans-Borgmeyer; M Wegner
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

6.  Mutation at the anophthalmic white locus in Syrian hamsters: haploinsufficiency in the Mitf gene mimics human Waardenburg syndrome type 2.

Authors:  C A Hodgkinson; A Nakayama; H Li; L B Swenson; K Opdecamp; J H Asher; H Arnheiter; T Glaser
Journal:  Hum Mol Genet       Date:  1998-04       Impact factor: 6.150

7.  Aberrant cell growth induced by avian winged helix proteins.

Authors:  B S Freyaldenhoven; M P Freyaldenhoven; J S Iacovoni; P K Vogt
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

8.  Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.

Authors:  A Watanabe; K Takeda; B Ploplis; M Tachibana
Journal:  Nat Genet       Date:  1998-03       Impact factor: 38.330

9.  Timing and pattern of cell fate restrictions in the neural crest lineage.

Authors:  P D Henion; J A Weston
Journal:  Development       Date:  1997-11       Impact factor: 6.868

10.  Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene.

Authors:  N Fuse; K Yasumoto; H Suzuki; K Takahashi; S Shibahara
Journal:  Biochem Biophys Res Commun       Date:  1996-02-27       Impact factor: 3.575

View more
  77 in total

Review 1.  Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.

Authors:  Ping Wan; Yongqing Hu; Li He
Journal:  Mol Cell Biochem       Date:  2011-04-26       Impact factor: 3.396

Review 2.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

Review 3.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

4.  Diversity in the molecular and cellular strategies of epithelium-to-mesenchyme transitions: Insights from the neural crest.

Authors:  Jean-Loup Duband
Journal:  Cell Adh Migr       Date:  2010-07-27       Impact factor: 3.405

Review 5.  Regional differences in neural crest morphogenesis.

Authors:  Bryan R Kuo; Carol A Erickson
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

Review 6.  In the beginning: Generating neural crest cell diversity.

Authors:  Christiana Ruhrberg; Quenten Schwarz
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

7.  FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

Authors:  Ethan V Abel; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

Review 8.  The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.

Authors:  Akinori Kawakami; David E Fisher
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

9.  FoxD3 regulates cranial neural crest EMT via downregulation of tetraspanin18 independent of its functions during neural crest formation.

Authors:  Corinne L Fairchild; Joseph P Conway; Andrew T Schiffmacher; Lisa A Taneyhill; Laura S Gammill
Journal:  Mech Dev       Date:  2014-02-28       Impact factor: 1.882

10.  A novel FoxD3 gene trap line reveals neural crest precursor movement and a role for FoxD3 in their specification.

Authors:  Tatiana Hochgreb-Hägele; Marianne E Bronner
Journal:  Dev Biol       Date:  2012-12-08       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.